ArticleVaccines2022

Antibody Response of Combination of BNT162b2 and CoronaVac Platforms of COVID-19 Vaccines against Omicron Variant.

Ka-Wa Khong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.